Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Founder and subclonal mutations in myelodysplastic syndromes and related myeloid neoplasms.

Best practice & research. Clinical haematology - 1 Sept 2020

Makishima Hideki

Abstract excerpt

Somatic mutations constitute key elements of the pathogenesis of myelodysplastic syndromes (MDS), a group of clonal hematologic neoplasms characterized by cytopenias, dysplasia and leukemic evolution. Whole exome sequencing followed by targeted deep sequencing in patients with MDS and related diseases has been performed cross-sectionally and serially. Bioinformatic analysis and confirmatory sequencing led to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Founder Effect
Share to Genome-Wide Association Study
Share to Hematologic Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Myelodysplastic Syndromes

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 33038978
DOI: 10.1016/j.beha.2020.101189

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Founder and subclonal mutations in myelodysplastic syndromes and related myeloid neoplasms.PMID 33038978Read ↗

Genetic and molecular characterization of myelodysplastic syndromes and related myeloid neoplasms.Semantic proximity Read ↗

Clinical and biological implications of driver mutations in myelodysplastic syndromes.Semantic proximity Read ↗

Dynamics of clonal evolution in myelodysplastic syndromes.Semantic proximity Read ↗

Clinical Implications of Genetic Mutations in Myelodysplastic Syndrome.Semantic proximity Read ↗

Myelodysplastic syndromes: Biological and therapeutic consequences of the evolving molecular aberrations landscape.Semantic proximity Read ↗

Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression.Semantic proximity Read ↗

Uncoding the genetic heterogeneity of myelodysplastic syndrome.Semantic proximity Read ↗

Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progressionSemantic proximity Read ↗

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms.Semantic proximity Read ↗

Mutations in myelodysplastic syndromes: Core abnormalities and CHIPping away at the edges.Semantic proximity Read ↗

Clonal evolution in myelodysplastic syndromes.Semantic proximity Read ↗

Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.